Urology Program Directors Update: Common Consultation Questions at the AUA 2015: RRC Rules You Want to Know Webcast (2016)
Program Directors need formal education and guidance with their duties as leaders, managers and organizers of resident education. The Next Accreditation System is creating a lot of changes which have created many questions regarding new processes and policies. It would be ideal if the Program Directors had a way of standardizing how to best implement the new changes to urology education. Program Coordinators/Administrators will need to understand the various changes and assist the Program Director in realizing the important educational tools that need to be instituted in their unique clinical learning environment.
There are new changes to the curriculum development, evaluation and assessment process for residents in urology. Program Directors need to know about how to implement the new changes using practical, thoughtful models. Program Coordinators/Administrators are essential to understanding the new concepts and designing new practical and meaningful solutions for the new policies and concepts.
- Practice Managers
At the conclusion of this course, participants should be able to:
- Build new partnerships to enhance the educational program
- Integrate and implement the Next Accreditation System into all aspects of the residency program
- Evaluate resident remediation scenarios regarding professional misconduct, academic concerns and behavioral issues
- Assess the program's areas for improvement for an ACGME Self-Study and Site Visit
- Engage faculty in the new system of evaluation: CCC and PEC
- Determine ways to evaluate resident wellness and solutions for resiliency
- Implement new tools to enhance teaching effectiveness
- Byron David Joyner, MD, MPA
- Randall B. Meacham, MD
- Laura Edgar, EDD, CAE
- E. Ann Gormley, MD
- Jessica L. Green
- Andrew C. Peterson, MD
- John Potts, III
- Mathew D. Sorensen, MD
- Mary Turner, RHIA, MJ
|Laura Edgar, EDD, CAE||Nothing to disclose|
|E. Ann Gormley, MD||SUFU Foundation||Leadership Position||No|
|Jessica L. Green||Nothing to disclose|
|Byron D. Joyner, MD||Nothing to disclose|
|Randall B. Meacham, MD||ACGME||Leadership Position||No|
|Andrew C. Peterson, MD||American Medical Systems INC||Meeting Participant or Lecturer, Scientific Study or Trial, Other||Yes|
|John Potts, III||Nothing to disclose|
|Mathew D. Sorensen, MD||Nothing to disclose|
|Mary Turner, RHIA, MJ||Nothing to disclose|
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Urological Association designates this enduring material for a maximum of 12.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices
It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Non-Physician Participation